Biofrontera Inc. (BFRI) Tops Q3 EPS by 18c

Biofrontera Inc. (NASDAQ: BFRI) reported Q3 EPS of ($0.11), $0.18 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $4.31 million.

For earnings history and earnings-related data on Biofrontera Inc. (BFRI) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Live Ventures (LIVE) Reports Q3 Loss of $0.34
• SanDisk unveils long-term growth strategy at 2026 Investor Day; Shares surge 12%